Chapter 1. DRUG TESTING MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. DRUG TESTING MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. DRUG TESTING MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. DRUG TESTING MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. DRUG TESTING MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
6.1. Consumables
6.2. Instruments
6.3. Rapid Testing Devices
6.4. Services
Chapter 7. DRUG TESTING MARKET – By Price Range
7.1. Urine Samples
7.2. Oral Fluid Samples
7.3. Hair Samples
7.4. Other Samples
Chapter 8. DRUG TESTING MARKET – By Application
8.1. Alcohol
8.2. Cannabis/Marijuana
8.3. Cocaine
8.4. Opioids
8.5. Amphetamine & Methamphetamine
8.6. LSD
8.7. Others
Chapter 9. DRUG TESTING MARKET – By End Use
9.1. Drug Testing Laboratories
9.2. Workplaces
9.3. Hospitals
9.4. Others
Chapter 10. DRUG TESTING MARKET – By Region
10.1. North America
10.2. Europe
10.3. Asia-P2acific
10.4. Latin America
10.5. The Middle East
10.6. Africa
Chapter 11. DRUG TESTING MARKET – By Companies
11.1. Companies 1
11.2. Companies 2
11.3. Companies 3
11.4. Companies 4
11.5. Companies 5
11.6. Companies 6
11.7. Companies 7
11.8. Companies 8
11.9. Companies 9
1110. Companies 10
2850
5250
4500
1800